MiniMed Group, Inc. last reported quarterly results on Sep 1, 2026, for Q1 FY2027 (the quarter ended Jul 31, 2026): revenue of $843.0 million and diluted EPS of $0.00. It usually reports 32–40 days after a quarter ends. Based on that pattern, the next release is estimated for around Dec 9, 2026.
Results for Q2 FY2027, the quarter ending around Oct 30, 2026. Expected on a Wednesday. Based on how many days after a quarter ends the company has reported recently. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 32–40 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Sep 1, 2026
32 days after quarter end
|
Q1 FY2027
ended Jul 31, 2026
|
843
|
0
|
0.00
|
|
Jun 3, 2026
40 days after quarter end
|
Q4 FY2026
ended Apr 24, 2026
|
837
|
-185
|
-0.69
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MMED (Nasdaq), MMEDV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Northridge, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 2062583
- Former names
- MDT Sub Holdings, Inc. (until May 30, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.